Article PDF
References
Imen A, Amal K, Ines Z, Sameh el F, Fethi el M, Habib G. Bullous dermatosis associated with gemcitabine therapy for non-small-cell lung carcinoma. Respir Med. 2006;100:1463–1465.
Kuku I, Kaya E, Sevinc A, Aydogdu I. Gemcitabineinduced erysipeloid skin lesions in a patient with malignant mesothelioma. J Eur Acad Dermatol Venereol. 2002; 16:271–272.
Chen YM, Liu JM, Tsai CM, Whang-Peng J, Perng RP. Maculopapular rashes secondary to gemcitabine injection for non-small-cell lung cancer. J Clin Oncol. 1996;14:1743–1744.
Kanai M, Matsumoto S, Nishimura T, Matsumura Y, Hatano E, Mori A, et al. Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy. Ann Oncol. 2010; 21:189–190.
Reid JM, Qu W, Safgren SL, Ames MM, Krailo MD, Seibel NL, et al. Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors. J Clin Oncol. 2004;22:2445–2451.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dua, V., Goyal, H. Gemcitabine induced skin rash. Indian Pediatr 50, 430 (2013). https://doi.org/10.1007/s13312-013-0109-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-013-0109-x